Live Analyst Rating Changes 20580 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Jason Goldberg
BARC

Jason Goldberg

Barclays
Wall Street Analyst
★★★★☆
#520
on 13Foresight · ranked by our own returns
60%
Success Rate
+6.6%
Average Return
55 of 92 calls profitable · +3.0% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 60% of Jason Goldberg's ratings turned a profit when each position was held for 1 year — averaging +6.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

157 Buy 108 Hold 46 Sell
Jason's Stock Coverage 34 ratings · 2026-08-08
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
ZION
Zions Bancorporation National Association
 Aug 07, 2026 SELL Hold
-7.6% avg upside
34 analysts
$72.00
2.48% Upside
 -0.0% ·
RF
Regions Financial
 Aug 07, 2026 SELL Buy
-5.5% avg upside
33 analysts
$30.00
4.48% Downside
 · ·
PNC
PNC Financial
 Aug 06, 2026 BUY Strong Buy
+2.3% avg upside
28 analysts
$284.00
12.52% Upside
 -0.1% ·
MS
Morgan Stanley
 Aug 05, 2026 BUY Buy
-12.6% avg upside
37 analysts
$262.00
21.19% Upside
 -0.9% ·
MTB
M&T Bank
 Aug 05, 2026 HOLD Buy
-9.0% avg upside
27 analysts
$267.00
6.70% Upside
 -0.6% ·
FITB
Fifth Third Bancorp
 Aug 05, 2026 BUY Strong Buy
-4.7% avg upside
32 analysts
$67.00
17.37% Upside
 -1.1% ·
KEY
KeyCorp
 Aug 05, 2026 HOLD Strong Buy
+6.4% avg upside
30 analysts
$24.00
5.57% Upside
 -1.6% ·
CFG
Citizens Financial
 Aug 05, 2026 BUY Strong Buy
+0.6% avg upside
25 analysts
$81.00
11.38% Upside
 -1.3% ·
GS
Goldman Sachs Group
 Aug 05, 2026 BUY Buy
-14.3% avg upside
33 analysts
$1245.00
19.77% Upside
 -2.0% ·
BNY
Bank of New York Mellon
 Aug 03, 2026 BUY Buy
-15.2% avg upside
27 analysts
$178.00
12.91% Upside
 +0.9% ·
TFC
Truist Financial
 Aug 03, 2026 SELL Buy
+5.2% avg upside
35 analysts
$56.00
7.06% Upside
 -1.3% ·
BAC
Bank of America
 Aug 03, 2026 BUY Strong Buy
-16.6% avg upside
46 analysts
$72.00
14.06% Upside
 +1.1% ·
NTRS
Northern
 Jul 31, 2026 HOLD Hold
-12.1% avg upside
22 analysts
$189.00
1.79% Upside
 +1.2% ·
STT
State Street
 Jul 31, 2026 HOLD Strong Buy
-9.3% avg upside
25 analysts
$200.00
8.22% Upside
 +1.9% ·
HBAN
Huntington Bancshares
 Jul 29, 2026 HOLD Strong Buy
+7.3% avg upside
27 analysts
$20.00
14.01% Upside
 +3.1% ·
WFC
Wells Fargo
 Jul 29, 2026 BUY Buy
-2.5% avg upside
39 analysts
$108.00
23.87% Upside
 +4.6% ·
ALLY
Ally Financial
 Jul 27, 2026 HOLD Strong Buy
+12.6% avg upside
28 analysts
$56.00
28.14% Upside
 +0.8% ·
FCNCA
First Citizens BancShares
 Jul 24, 2026 HOLD Buy
+0.8% avg upside
18 analysts
$2376.00
7.15% Upside
 +3.1% ·
USB
US Bancorp
 Jul 16, 2026 BUY Strong Buy
+0.4% avg upside
34 analysts
$75.00
17.25% Upside
 -0.1% ·
C
Citigroup
 Jul 15, 2026 BUY Strong Buy
-11.8% avg upside
37 analysts
$154.00
14.05% Upside
 +0.6% ·
JPM
JPMorgan Chase
 Jul 15, 2026 BUY Strong Buy
-23.8% avg upside
47 analysts
$420.00
17.57% Upside
 +3.1% ·
COF
Capital One Financial
 Sep 17, 2024 HOLD Strong Buy
-5.0% avg upside
41 analysts
$154.00
29.27% Downside
 +57.4% ·
FRCB
First Republic Bank
 Apr 24, 2023 HOLD Buy
+19690004.2% avg upside
22 analysts
$15.00
3749900.01% Upside
 · ·
RELY
Remitly Global
 Apr 14, 2023 BUY Strong Buy
+12.7% avg upside
14 analysts
$20.00
18.01% Downside
 +10.7% ·
CYTK
Cytokinetics
 Apr 03, 2023 BUY Strong Buy
+16.3% avg upside
36 analysts
$58.00
24.38% Downside
 +88.1% ·
AMRX
Amneal Pharmaceuticals
 Mar 02, 2023 BUY Strong Buy
-2.3% avg upside
18 analysts
$7.00
61.31% Downside
 +174.9% ·
ELAN
Elanco Animal Health
 Feb 17, 2023 HOLD Strong Buy
+40.6% avg upside
18 analysts
$18.00
18.56% Downside
 +23.8% ·
IDXX
Idexx Laboratories
 Jan 16, 2023 BUY Buy
+24.2% avg upside
17 analysts
$582.00
0.84% Downside
 +8.3% ·
AMAL
Amalgamated Bank
 Jan 28, 2022 BUY Buy
-36.3% avg upside
8 analysts
$22.00
55.74% Downside
 +41.1% ·
SICP
Silvergate Capital
 May 18, 2021 HOLD Hold
+17811.1% avg upside
12 analysts
$135.00
29899.93% Upside
 · ·
AUB
Atlantic Union Bankshares
 Apr 13, 2021 HOLD Strong Buy
+5.5% avg upside
14 analysts
$43.00
2.88% Upside
 -2.0% ·
EWBC
East West Bancorp
 Oct 09, 2015 BUY Strong Buy
-11.1% avg upside
24 analysts
$50.00
62.13% Downside
 +3.1% ·
TCBI
Texas Capital Bancshares
 Apr 26, 2012 HOLD Hold
-10.8% avg upside
23 analysts
$40.00
59.72% Downside
 +11.1% ·
FHN
First Horizon
 Jul 09, 2010 HOLD Buy
-9.5% avg upside
31 analysts
$15.00
41.07% Downside
 -21.7% ·
🔒 29 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Jason Goldberg — Frequently Asked Questions
How accurate are Jason Goldberg's stock ratings?
Based on the calls 13Foresight could measure, about 60% of Jason's ratings were profitable over a one-year hold, with an average return of +6.6% per rating, or +3.0% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Jason ranked on 13Foresight?
Jason Goldberg is currently ranked #520 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Jason cover?
Jason most recently has ratings on ZION, RF, PNC, MS, MTB, FITB, KEY, CFG, GS, BNY, TFC, BAC and 22 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.